Sign in
4/A

Changes in Ownership

BIO-TECHNE Corp Filed Acc 0000914190-20-000405

Options or other derivatives

  • Chief Financial Officer acquired 7,391 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Hippel James · Chief Financial Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2020-11-11 Exercise or conversion : show line 1 in the form Stock Option (Right to Buy) −7,391 59,942 D
Loading xslF345X03/edgar.xml…